| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/04/2007 | US7264923 Infected macrophage that is deficient in a STAT-1-dependent anti-viral pathway, an interferon receptor-dependent anti-viral pathway, and/or a double-stranded RNA-dependent serine/threonine protein kinase-dependent anti-viral pathway |
| 09/04/2007 | US7264818 BAV packaging regions and E1 transcriptional control regions |
| 09/04/2007 | US7264816 an isolated unusually virulent form of a calicivirus that results in a highly contagious and fatal hemorrhagic fever syndrome; immunizing cats; vaccines; detecting in a sample |
| 09/04/2007 | US7264812 Nucleic acid sequences encoding Ostertagia ostertagi proteins and parts of such nucleic acid sequences encode an immunogenic fragment of such proteins; for use in vaccines |
| 09/04/2007 | US7264811 Purified active HCV NS2/3 protease |
| 09/04/2007 | US7264810 Scaffolds comprising epitopes and genetic engineered proteins of bacteriophages, used as vaccines, anticarcinogenic agents or antiallergens |
| 09/04/2007 | US7264808 Synthetic peptide for neurological disorders |
| 09/04/2007 | US7264807 Administering to human therapeutically effective amount of antibody which binds to tropomyosin isoform associated with ulcerative colitis |
| 09/04/2007 | US7264802 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 09/04/2007 | US7264801 Antibody for use in the treatment of cancer, inflammation and immunological responses |
| 09/04/2007 | US7264793 Numb protein expression inhibitors by Musashi |
| 08/30/2007 | WO2007098420A2 Peptides that block the binding of igg to fcrn |
| 08/30/2007 | WO2007098201A2 Shiga toxoid chimeric proteins |
| 08/30/2007 | WO2007098170A1 Antibodies against human il-22 and uses therefor |
| 08/30/2007 | WO2007097903A2 Hiv fusion inhibitor peptides with improved biological properties |
| 08/30/2007 | WO2007097828A2 Method for identifying and validating dominant t helper cell epitopes using an hla-dm-assisted class ii binding assay |
| 08/30/2007 | WO2007097812A2 Therapeutic anti-her2 antibody fusion polypeptides |
| 08/30/2007 | WO2007097778A2 Novel restriction endonucleases, dna encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity |
| 08/30/2007 | WO2007097493A1 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh |
| 08/30/2007 | WO2007097469A1 A dominant negative peptide of imp-3, polynucleotide encoding the same, pharmaceutical composition containing the same, and methods for treating or preventing cancer |
| 08/30/2007 | WO2007097361A1 Immunoglobulin affinity ligand |
| 08/30/2007 | WO2007097251A1 PEPTIDE VACCINE FOR INDUCING PRODUCTION OF ANTI-AMYLOID-β-PEPTIDE ANTIBODY |
| 08/30/2007 | WO2007097113A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 08/30/2007 | WO2007097097A1 Ammonia transporter gene and use thereof |
| 08/30/2007 | WO2007097096A1 Ammonia transporter gene and use thereof |
| 08/30/2007 | WO2007097095A1 Aromatic amino acid transporter gene and use thereof |
| 08/30/2007 | WO2007097093A1 Branched amino acid transporter gene and use thereof |
| 08/30/2007 | WO2007097089A1 Gene encoding acetolactate synthase and use thereof |
| 08/30/2007 | WO2007097088A1 Gene encoding protein with vicinal diketone or diacetyl-reducing activity and use thereof |
| 08/30/2007 | WO2007096899A2 Affinity polypeptide for purification of recombinant proteins |
| 08/30/2007 | WO2007096859A2 Protection of the retina against laser injury by adnf peptides such as nap and sal |
| 08/30/2007 | WO2007096854A1 Compositions and methods for modulating an immune response |
| 08/30/2007 | WO2007096528A2 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof |
| 08/30/2007 | WO2007096431A1 Insulin derivatives |
| 08/30/2007 | WO2007096406A1 A method of removing a non-metallic protein inhibitor from a liquid pharmaceutical preparation |
| 08/30/2007 | WO2007096398A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases |
| 08/30/2007 | WO2007096332A1 Single-chain insulin analogues and pharmaceutical formulations thereof |
| 08/30/2007 | WO2007096201A2 Novel upases and uses thereof |
| 08/30/2007 | WO2007096199A2 Differential diagnostics and therapy of virally induced heart muscle disease |
| 08/30/2007 | WO2007096185A1 Primate model for orthopox virus infections |
| 08/30/2007 | WO2007096116A1 Coagulation factor x polypeptides with modified activation properties |
| 08/30/2007 | WO2007095867A1 Immunomodulatory and anti-tumour peptides |
| 08/30/2007 | WO2007095737A1 Combination therapy for the treatment of diabetes comprising an exendin agonist and a gastrin compound |
| 08/30/2007 | WO2007095661A1 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 08/30/2007 | WO2007095660A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| 08/30/2007 | WO2007095659A1 Peptides and peptide derivatives, preparation thereof and the use thereof for preparing a therapeutic and/or preventative medicament |
| 08/30/2007 | WO2007079605A3 Template-fixed peptidomimetics with antimicrobial activity |
| 08/30/2007 | WO2007079141A9 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 08/30/2007 | WO2007058776A3 Hepatocyte growth factor intron fusion proteins |
| 08/30/2007 | WO2007053570A3 A polypeptide complex of trpm8 and calmodulin and its uses thereof |
| 08/30/2007 | WO2007052102A3 Modified green fluorescent proteins and methods for using same |
| 08/30/2007 | WO2007022012A3 Differentially protected orthogonal lanthionine technology |
| 08/30/2007 | WO2007010413A3 Modifed esat-6 molecules and improved vaccine strains of mycobacterium bovis bcg |
| 08/30/2007 | WO2006136982A3 An isolated recombinant vaccinia virus complement control protein (hrvcp) polypeptide |
| 08/30/2007 | WO2006028561A3 Novel purified fabi polypeptides from fransicella tularensis |
| 08/30/2007 | WO2005062954A3 Modulation of hcn channels by second messengers |
| 08/30/2007 | WO2004009836A3 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 08/30/2007 | WO2003095622A3 Proteins associated with cell growth, differentiation, and death |
| 08/30/2007 | US20070204369 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof |
| 08/30/2007 | US20070204368 Banana Resistance Genes And Uses Thereof |
| 08/30/2007 | US20070204365 Cocoa polypeptides and their use in the production of cocoa and chocolate flavor |
| 08/30/2007 | US20070204363 producing a plant cell or plant with altered lignin composition by down-regulating expression of an endogenous polypeptide that has ferulate 5-hydroxylase (F5H) activity |
| 08/30/2007 | US20070204355 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein |
| 08/30/2007 | US20070203330 Process For Removing Fibronectin From Plasma Fractions |
| 08/30/2007 | US20070203329 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders |
| 08/30/2007 | US20070203328 Novel hemopoietin receptor protein, NR12 |
| 08/30/2007 | US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces |
| 08/30/2007 | US20070203325 Integrase-dirived HIV-inhibiting agents |
| 08/30/2007 | US20070203088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease |
| 08/30/2007 | US20070203071 Conformationally Constrained Parthyroid Hormone (Pth) Analogs |
| 08/30/2007 | US20070203070 28 human secreted proteins |
| 08/30/2007 | US20070203068 Stimulation of beta cell proliferation |
| 08/30/2007 | US20070203067 Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties |
| 08/30/2007 | US20070203064 TLR3 Glycosylation Site Muteins and Methods of Use |
| 08/30/2007 | US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties |
| 08/30/2007 | US20070203061 Adiponectin expression-inducing agents and uses thereof |
| 08/30/2007 | US20070203059 Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same |
| 08/30/2007 | US20070203058 Novel Glp-1 Derivatives |
| 08/30/2007 | US20070203057 Compounds and methods for modulating adhesion molecule function |
| 08/30/2007 | US20070203054 Fragments of nkp44 for targeting viral-infected and tumor cells |
| 08/30/2007 | US20070202591 Nucleotide sequences coding streptococcal pyrogenic exotoxin A and B proteins for treatment and prevention of food poisoning, bacterial arthritis and autoimmune disorders |
| 08/30/2007 | US20070202587 Recombinant AAV production in mammalian cells |
| 08/30/2007 | US20070202575 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 08/30/2007 | US20070202573 Soluble fusion proteins comprising heterologous polypeptides |
| 08/30/2007 | US20070202568 Insertion of Furin Protease Cleavage Sites in Membrane Proteins and Uses Thereof |
| 08/30/2007 | US20070202551 TGFBeta |
| 08/30/2007 | US20070202550 Novel G protein-coupled receptor protein, its DNA and ligand thereof |
| 08/30/2007 | US20070202539 Methods for quantitative proteome analysis of glycoproteins |
| 08/30/2007 | US20070202535 Methods For Analyzing Interactions Between Proteins And Sugar Chains |
| 08/30/2007 | US20070202512 Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof |
| 08/30/2007 | US20070202501 Proteins Expressed In Ink Cells |
| 08/30/2007 | US20070202498 comprising at least two chemically different fluorophores, providing a donor and an acceptor respectively, connected together by at least one linker moiety and bonded to a binder moiety; obtaining fluorescence enhancement by energy transfer enabled with binder molecules in diagnostic applications |
| 08/30/2007 | US20070202132 Allergenic proteins and peptides from dog dander and uses therefor |
| 08/30/2007 | US20070202129 Use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture |
| 08/30/2007 | US20070202127 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 08/30/2007 | US20070202125 Inhibiting rejection of a graft |
| 08/30/2007 | US20070202123 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids |
| 08/30/2007 | US20070202122 Non-splicing variants of gp350/220 |
| 08/30/2007 | US20070202121 SPAS-1 cancer antigen |
| 08/30/2007 | US20070202110 Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer |